MedShadow

Regular marijuana use may greatly increase risk of developing psychosis and FDA warns company selling homeopathic meds containing snake venom for pain.

Because of potential side effects such as loss of consciousness, Zulresso will only be available in facilities where patients are monitored during infusion.

Proton pump inhibitors (PPIs) such as Nexium and Prilosec are again linked to an increased risk of kidney damage.

Bempedoic acid, however, is likely several years from potential approval since a cardiovascular outcomes trial is still needed.

FDA Commissioner Scott Gottlieb’s interim replacement named and inactive ingredients in drugs can cause allergic reactions.

Swedish study finds that taking an ADHD med actually reduces number of seizures compared with periods in which no ADHD drug is taken.

DOJ is seeking documents from Acadia Pharmaceuticals about its marketing of the Parkinson’s psychosis drug Nuplazid.

Kaiser Health News investigation finds many serious medical device adverse events hidden in database inaccessible to the public.

FDA Commissioner Scott Gottlieb is stepping down and study finds acne drug Accutane not associated with depression or mood disorders.

Spravato, a nasal spray for treatment-resistant depression, is the first antidepressant approved with a new mechanism of action in decades.

Study looked at more than 650,000 children and also found no link between other vaccines and autism.

Study finds having anxiety and having a history of suicidal ideation can put you at higher risk of experiencing side effects such as hallucinations.